Fifteen Headache-Day Threshold Does Not Capture Migraine Burden
Findings raise questions about the current headache frequency used for classification of migraine headaches
Headache
Review IDs Reasons for Disparities in Headache Treatment
Factors that contribute to disparities include racism, socioeconomic status and insurance status, geographic disparities
Managing Chronic Headache During the COVID-19 Pandemic: A Q&A
Matthew Robbins, MD, author of “COVID-19 and headache: a primer for trainees,” details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.
Butalbital/APAP Capsules Launched for Complex Tension Headache
The label includes a Boxed Warning describing the risk of hepatotoxicity associated with APAP. Most cases of liver injury were associated with APAP doses >4000mg daily and often involved >1 APAP-containing product.
Antidepressant Medications and Headache: Is There a Link?
Compared to placebo, selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly higher risk of headache (risk ratio [RR] 1.06, 95% CI: 1.00 to 1.13; P =.045).
Migraine Treatment With Needle-Free Delivery System No Longer Available
Both strengths of Sumavel DosePro have now been discontinued.
Lannett Approved for Generic Imitrex Nasal Spray
Lannett announced that the FDA has approved Sumatriptan Nasal Spray, the generic version of GlaxoSmithKline’s Imitrex Nasal Spray.
Triple Combination Therapy More Effective for Tension-Type Headache
Compared to acetaminophen monotherapy, the combination of acetylsalicylic acid, caffeine and acetaminophen is more effective in treating episodic tension-type headaches, says a new study.
Migraine and Headache Treatments
Adult doses for migraine and headache treatments including barbiturates, ergot alkaloids, and NSAIDs.
